InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the complete record of transactions filed by Sank Leonard, 董事. Director active across 1 company, notably Oramed Pharmaceuticals INC.. Aggregated, 6 disclosures have been logged. Activity tracked since 8 August 2022. The latest transaction was disclosed on 8 August 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Sank Leonard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
30,000 股Common StockSEC:0001213900-25-052620:0
30,000 股Common StockSEC:0001209191-24-001143:0
30,000 股Common StockSEC:0001209191-23-024942:0
20,000 股@ US$4.08100.0% 占其流量Common StockSEC:0001209191-22-045207:0
12,000 股Common StockSEC:0001209191-22-043766:0
6,000 股Common StockSEC:0001213900-22-000822:0
6 条申报中的 6 条
About Sank Leonard
Sank Leonard is Administrateur at Oramed Pharmaceuticals INC. (XNAS). He has 6 filings in total, and across the 6 recent filings we hold, the most frequent transaction nature is Awards. The recent filings cover the period from 2022-01-05 to 2025-06-09, with an amount of EUR 80018.5931156767 in one filing published on 2022-08-10.
